EMGLIF 25MG TAB 28S
EMGLIF 25MG Tablet contains Empagliflozin, an SGLT2 inhibitor used for the treatment of Type 2 Diabetes Mellitus. It lowers blood glucose by helping the kidneys remove excess sugar through urine. Besides improving blood sugar control, Empagliflozin has proven cardiovascular and kidney benefits, making it an excellent choice for diabetic patients at risk of heart disease or chronic kidney disease. When combined with a healthy diet and regular exercise, EMGLIF helps support long-term diabetes management.
Uses
- Type 2 Diabetes Mellitus
- Blood sugar control
- Reduction of cardiovascular risk in diabetic patients
- Kidney protection in eligible patients
Benefits
- Effectively lowers blood glucose
- Supports weight reduction
- May help lower blood pressure
- Reduces cardiovascular complications
- Helps protect kidney function
Possible Side Effects
- Frequent urination
- Urinary tract infection
- Genital fungal infection
- Increased thirst
- Dehydration
- Dizziness
Pharmacist Advice
Maintain adequate hydration during treatment. Monitor blood sugar regularly and practice good personal hygiene to reduce the risk of urinary and genital infections. Continue your diabetic diet and exercise routine.